Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
European Journal of Cancer (Oxford, England : 1990)|December 28, 2016
Major infections, secondary cancers and autoimmune diseases occur in different clinical subsets of chronic lymphocytic leukaemia patientsAndrea Visentin, Silvia Imbergamo, Carmela Gurrieri, et al.
Blood|October 4, 2012
S1P1 expression is controlled by the pro-oxidant activity of p66Shc and is impaired in B-CLL patients with unfavorable prognosisNagaja Capitani, Laura Patrussi, Livio Trentin, et al.
EMBO Reports|May 9, 2020
Hexokinase 2 displacement from mitochondria-associated membranes prompts Ca<sup>2+</sup> -dependent death of cancer cellsFrancesco Ciscato, Riccardo Filadi, Ionica Masgras, et al.
British Journal of Haematology|May 6, 2024
Exploring the prognostic role of complex karyotype in chronic lymphocytic leukaemia patients treated with venetoclax-based regimensAndrea Serafin, Alessandro Cellini, Chiara Adele Cavarretta, et al.
Hematological Oncology|September 26, 2020
Ibrutinib in relapsed hairy cell leukemia variant: A case report and review of the literatureAndrea Visentin, Silvia Imbergamo, Valentina Trimarco, et al.
Blood|May 2, 2015
Lyn sustains oncogenic signaling in chronic lymphocytic leukemia by strengthening SET-mediated inhibition of PP2AFrancesca Zonta, Mario Angelo Pagano, Livio Trentin, et al.
Haematologica|September 22, 2011
Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomesEnrica Rampazzo, Laura Bonaldi, Livio Trentin, et al.
Blood|November 12, 2020
Enhanced IL-9 secretion by p66Shc-deficient CLL cells modulates the chemokine landscape of the stromal microenvironmentLaura Patrussi, Noemi Manganaro, Nagaja Capitani, et al.
BMC Medicine|June 30, 2026
Focal adhesion kinase FAK interplays with ROR1 in the aggressiveness of chronic lymphocytic leukemiaMaria Castronuovo, Guido Capasso, Allison Beltrame, et al.
International Journal of Cancer|May 3, 2019
HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemiaFederica Frezzato, Flavia Raggi, Veronica Martini, et al.
Pageof 6